Oncology

Clinical Management Strategies in Acute Lymphoblastic Leukemia

ID: 08052009

Clinical Management Strategies in Acute Lymphoblastic Leukemia

Clinical Management Strategies in Acute Lymphoblastic Leukemia
VN:RO [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Course Length:

  • 60 minutes

Language:

  • English

Course Features:

  • Audio narration
  • Progress checks
  • Pop quizzes
  • Final assessment

Target Audience:

  • Medical professionals
  • Medical students
  • Pharmaceutical representatives
  • Nurses

Description:

The Clinical Management Strategies in Acute Lymphoblastic Leukemia learning program is designed to give insight into the treatment regimen of acute lymphoblastic leukemia (ALL) in children, adolescents, and adults. It also discusses risk stratification. What are the main treatment protocols and guidelines for ALL? Is therapy different in children than in adults? How does the Philadelphia chromosome, an important ALL prognostic factor, influence the treatment options for a patient? What is “CNS prophylaxis”? This program aims to provide answers to these questions.

Upon completion of this learning program, you will be able to:

  • Recall key information about the ALL treatment guidelines.
  • Recall the specifics of the ALL treatment environment.
  • Discuss the assessment of response to ALL treatment.
  • Describe the treatment pathways in pediatric ALL patients.
  • Describe the treatment pathways in adult ALL patients.
  • List the complications that can arise during ALL treatment and describe their management.
  1. WELCOME
    1. DISCLAIMER
    2. NAVIGATION INSTRUCTIONS
    3. INTRODUCTION
    4. LEARNING OBJECTIVES
  2. TREATMENT STRATEGIES AND GUIDELINES
    1. INTRODUCTION
    2. TREATMENT GUIDELINES FOR ALL
    3. THE ALL TREATMENT ENVIRONMENT
    4. POP QUIZ
    5. ASSESSMENT OF RESPONSE TO ALL TREATMENT
    6. PROGRESS CHECK
    7. SECTION SUMMARY
  3. TREATMENT PATHWAYS FOR PEDIATRIC PATIENTS
    1. PHASES OF TREATMENT
    2. THE BERLIN-FRANKFURT-MÜNSTER PROTOCOL
    3. RISK-BASED TREATMENT ASSIGNMENT
    4. POP QUIZ
    5. TREATMENT OF ALL PEDIATRIC PATIENTS
    6. CNS PROPHYLAXIS
    7. TREATMENT OF REFRACTORY ALL IN CHILDREN
    8. TREATMENT OF RELAPSED ALL IN CHILDREN
    9. ALLOGENEIC STEM CELL TRANSPLANTATION
    10. PROGRESS CHECK
    11. SECTION SUMMARY
  4. TREATMENT PATHWAYS FOR ADULT PATIENTS
    1. INTRODUCTION
    2. TREATMENT PROTOCOLS IN ADULTS
    3. RISK STRATIFICATION FOR AYA AND ADULT ALL PATIENTS
    4. POP QUIZ
    5. TREATMENT OF AYA PATIENTS
    6. TREATMENT OF ADULT PATIENTS
    7. CNS PROPHYLAXIS
    8. TREATMENT OF REFRACTORY OR RELAPSED DISEASE IN ADULTS
    9. ALLOGENEIC STEM CELL TRANSPLANTATION
    10. PROGRESS CHECK
    11. SECTION SUMMARY
  5. MANAGING TREATMENT COMPLICATIONS
    1. INTRODUCTION
    2. SIDE EFFECTS OF CHEMOTHERAPY
    3. INFECTIONS
    4. BLEEDING
    5. PROGRESS CHECK
    6. SECTION SUMMARY
  6. TEST YOUR ACQUIRED KNOWLEDGE
    1. SUMMARY
    2. FINAL ASSESSMENT
  7. END OF PROGRAM
  8. GLOSSARY
  9. REFERENCES



Return to catalog

Our Latest News

A.D.A.M. OnDemand™ is the most comprehensive library of off-the-shelf medical eLearning programs for patients, students, health care professionals and the pharmaceutical industry.
READ MORE
Whether you already have a learning management system (LMS) or need assistance hosting your programs, we can help you deliver and track training today!
READ MORE
A.D.A.M., the most credible source of health care information and multimedia visual learning assets for health care organizations, has the solutions you need to succeed in todays competitive...
READ MORE